Hims & Hers Health (NYSE: HIMS) tumbled 5.6% through 12:20 p.m. ET Thursday after Bank of America analysts gave mixed ...
(Reuters) - Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage ...
Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...
Former Tennessee football offensive lineman Trey Teague is sharing lessons learned in Knoxville with his daughter, Lilly, a ...
Travis Coy is using his Big Pharma bona fides to prioritize business development at the diversified and growing company.
President Trump is going scorched earth on America’s major European trading partners. Vowing to impose reciprocal tariffs on ...
While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...
While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Detailed price information for Palantir Technologies Inc Cl A (PLTR-Q) from The Globe and Mail including charting and trades.
Defense Secretary Pete Hegseth has ordered senior military and Defense Department officials to draw up plans to cut 8 percent ...
As HR's strategic role evolves, people professionals must leverage tech alongside human skills to drive success, says BVI ...
It’s true: old dogs can learn new tricks — and we’re proof of that! I’m Lilly, an affectionate golden girl, here with my ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results